Recap of Recent Radiopharmaceutical Deals

Radiopharmaceuticals are one of the most dynamic segments of BioPharma. Here is a deep dive into some notable deals, and how the biggest companies are approaching the space.

July 15, 2024

The Constant Evolution of Biopharma: A Decade of Transformation

Biopharma companies reinvent themselves every decade, driven by innovation and portfolio changes. Learn about the shifting best-sellers, impacts on sales teams, brand awareness, and strategic decisions in the industry.

July 08, 2024

Top 15 Immunology Drugs by Sales of Q1 '24

Explore the shifting landscape of the immunology market as top-selling drugs face varying futures. Humira's sales slow but stabilize, with AbbVie's Skyrizi and Rinvoq picking up momentum, projecting a combined sales forecast of $27B by 2027. Meanwhile, J&J's Stelara braces for generic competition in early 2025, and Dupixent's sales soar, potentially expanding indications to include COPD.

July 01, 2024

Novartis Navigates Patent Cliff with Robust Pipeline and Strategic Focus

Facing upcoming patent expirations, Novartis is reinforcing its pipeline with promising drugs like Kisqali and Pluvicto. Despite challenges, including complex manufacturing for radioligand therapies, the company's strategic focus and recent divestitures position it well to manage future competition.

June 25, 2024

Top 10 Biopharma Fundraises in April 2024

In April 2024, the top 10 biopharma fundraising rounds totaled more than $2B, yet more than half the haul was from just two companies

May 14, 2024

Which Large Pharma Companies Spend the Most on M&A?

In the past 2 years, 10 of the largest biopharma companies spent a combined $170 BILLION on M&A. But why do some spend much more than others?

May 07, 2024

Top 15 Biopharma Companies by Oncology Sales

Oncology is the largest single therapeutic area within the global biopharma market, worth over $200B. While a lot of analysis is focused on sales of individual drugs, it is also helpful to take a look at oncology sales by company overall to help paint a fuller picture.

May 07, 2024

The 15 Biggest Biotech and Pharma Fundraisings in Q1 2024

The 15 largest biotech fundraisings picked up ~$2.8B in Q1, showing that capital markets are seeing improved sentiment after 2 years of difficulty.

May 03, 2024

Top 10 Pharma Companies by Revenue in 2023

The 10 largest pharma companies generated close to $500 billion in revenue in 2023. Over the past 10 years, they grew their sales by ~$160B through a combination of blockbuster products and transformational M&A deals.

May 03, 2024

Upcoming Patent Expirations and LOEs for the 15 Biggest Drugs by Sales

The biopharma industry has ~$200B in revenue at risk in the next 5 years, including 8 out of the top 15 drugs. Here's a closer look behind the upcoming patent cliff:

April 23, 2024